UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 40-F
(Check One)
| ☐ | REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 |
OR
| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the fiscal year ended December 31, 2016 | Commission file number 1-14942 |
MANULIFE FINANCIAL CORPORATION
(Exact name of Registrant as specified in its charter)
Canada
(Province or other jurisdiction of incorporation or organization)
6311
(Primary Standard Industrial Classification Code Number (if applicable))
Not applicable
(I.R.S. Employer Identification Number (if applicable))
200 Bloor Street East, NT 11, Toronto, Ontario, Canada M4W 1E5
(416) 926-3000
(Address and Telephone Number of Registrant’s Principal Executive Offices)
James Gallagher, Manulife Financial Corporation, 601 Congress Street, Boston, MA 02210-2805 (617) 663-3000
(Name, address (including zip code) and telephone number
(including area code) of agent for service in the United States)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
| Title of each class | Name of each exchange on which registered | |
| Common Shares | New York Stock Exchange |
Securities registered or to be registered pursuant to Section 12(g) of the Act. None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. 4.90% Senior Notes due 2020, 4.150% Senior Notes due 2026, and 5.375% Senior Notes due 2046
For annual reports, indicate by check mark the information filed with this Form:
| ☒ Annual Information Form | ☒ Audited Annual Financial Statements |
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report:
| Common Shares |
1,975,454,900 | |||
| Class A Shares Series 2 |
14,000,000 | |||
| Class A Shares Series 3 |
12,000,000 | |||
| Class 1 Shares Series 3 |
6,335,831 | |||
| Class 1 Shares Series 4 |
1,664,169 | |||
| Class 1 Shares Series 5 |
8,000,000 | |||
| Class 1 Shares Series 7 |
10,000,000 | |||
| Class 1 Shares Series 9 |
10,000,000 | |||
| Class 1 Shares Series 11 |
8,000,000 | |||
| Class 1 Shares Series 13 |
8,000,000 | |||
| Class 1 Shares Series 15 |
8,000,000 | |||
| Class 1 Shares Series 17 |
14,000,000 | |||
| Class 1 Shares Series 19 |
10,000,000 | |||
| Class 1 Shares Series 21 |
17,000,000 | |||
| Class 1 Shares Series 23 |
19,000,000 |
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).
Yes ☐ No ☒
40-F 2
Principal Documents
The following documents, filed as exhibits 99.1, 99.2 and 99.3 hereto, are hereby incorporated by reference into this Annual Report:
| (a) | Consolidated Financial Statements for the fiscal year ended December 31, 2016; |
| (b) | Management’s Discussion and Analysis for the fiscal year ended December 31, 2016; and |
| (c) | Annual Information Form dated February 9, 2017 for the fiscal year ended December 31, 2016. |
40-F 3
Certifications and Disclosure Regarding Controls and Procedures.
(a) Certifications. The Certificates required by Rule 13a-14(a) and (b) are set forth in Exhibits 99.4, 99.5, 99.6 and 99.7 to this Annual Report on Form 40-F.
(b) Disclosure Controls and Procedures. The conclusions of Manulife’s principal executive and principal financial officers regarding the effectiveness of Manulife’s disclosure controls and procedures as at December 31, 2016 are set forth under the heading “Controls and Procedures – Disclosure Controls and Procedures” in the Company’s Management’s Discussion and Analysis for the fiscal year ended December 31, 2016, filed as Exhibit 99.2 to this Annual Report on Form 40-F.
(c) Management’s Annual Report on Internal Control over Financial Reporting. Management’s report on Manulife’s internal control over financial reporting is set forth under the heading “Controls and Procedures - Management’s Report on Internal Control over Financial Reporting” in the Company’s Management’s Discussion and Analysis for the fiscal year ended December 31, 2016, filed as Exhibit 99.2 to this Annual Report on Form 40-F.
(d) Attestation Report of the Registered Public Accounting Firm. Ernst & Young LLP’s attestation report on management’s assessment of internal control over financial reporting is set forth under the heading “Independent Auditors’ Report of Registered Public Accounting Firm on Internal Control Under Standards of The Public Company Accounting Oversight Board (United States)” in the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2016, filed as Exhibit 99.1 to this Annual Report on Form 40-F.
(e) Changes in Internal Control Over Financial Reporting. Information regarding any changes in Manulife’s internal control over financial reporting is set forth under the heading “Controls and Procedures – Changes in Internal Control over Financial Reporting” in the Company’s Management’s Discussion and Analysis for the fiscal year ended December 31, 2016, filed as Exhibit 99.2 to this Annual Report on Form 40-F.
Audit Committee Financial Expert.
Information regarding audit committee financial experts is set forth under the heading “Audit Committee” in the Company’s Annual Information Form (“AIF”) dated February 9, 2017 for the fiscal year ended December 31, 2016, filed as Exhibit 99.3 to this Annual Report on Form 40-F.
40-F 4
Code of Business Conduct and Ethics.
The Company has adopted a Code of Business Conduct and Ethics (“Code”) that applies to all directors, officers and employees, and that qualifies as a “code of ethics” as that term is defined in Form 40-F. The Code is posted on the corporate governance section of our website and is available for viewing at: http://www.manulife.com/servlet/servlet.FileDownload?file=00P5000000a1MbpEAE
Since the adoption of the Code, there have been amendments to the Code to provide clarity and to expand on elements of the existing Code. There have not been any waivers, including implied waivers, from any provision of the Code.
Principal Accountant Fees and Services.
Information regarding the fees billed by Ernst & Young LLP is set forth under the heading “Audit Committee - External Auditor Service Fees” in the Company’s Annual Information Form dated February 9, 2017 for the fiscal year ended December 31, 2016, filed as Exhibit 99.3 to this Annual Report on Form 40-F.
Pre-Approval Policies and Procedures.
Information regarding Manulife’s pre-approval policies and procedures is set forth under the heading “Audit Committee – Pre-Approval Policies and Procedures” in the Company’s Annual Information Form dated February 9, 2017 for the fiscal year ended December 31, 2016, filed as Exhibit 99.3 to this Annual Report on Form 40-F.
Off-Balance Sheet Arrangements.
Information regarding Manulife’s off-balance sheet arrangements is set forth in the discussion of risk in the Company’s Management’s Discussion and Analysis for the fiscal year ended December 31, 2016, filed as Exhibit 99.2 to this Annual Report on Form 40-F. The notes to the Consolidated Financial Statements for the fiscal year ended December 31, 2016, filed as Exhibit 99.1 to this Annual Report on Form 40-F include the following disclosures related to off-balance sheet arrangements:
| Note 5 |
Derivative and Hedging Instruments | |
| Note 10 |
Risk Management - Securities Lending, Repurchase and Reverse Repurchase Transactions | |
| Note 17 |
Interests in Structured Entities | |
| Note 18 |
Commitments and Contingencies |
Tabular Disclosure of Contractual Obligations.
Information regarding Manulife’s contractual obligations is set forth under the heading “Contractual Obligations” in the Company’s Management’s Discussion and Analysis for the fiscal year ended December 31, 2016, filed as Exhibit 99.2 to this Annual Report on Form 40-F.
40-F 5
Identification of the Audit Committee.
Information regarding the Audit Committee of Manulife’s Board of Directors is set forth under the heading “Audit Committee - Composition of the Audit Committee in 2016” in the Company’s Annual Information Form (“AIF”) dated February 9, 2017 for the fiscal year ended December 31, 2016, filed as Exhibit 99.3 to this Annual Report on Form 40-F.
Independence of Directors.
A majority of the directors and all members of the Board’s standing committees must be independent so that the Board operates independently of management.
A director is independent if he or she does not have a direct or indirect relationship with the Company that could reasonably be expected to interfere with the director’s ability to exercise independent judgment. The Company has established an independence policy for the Board which is consistent with applicable legal and regulatory requirements, including those established under Canadian and U.S. securities law, the Insurance Companies Act (Canada) and the rules of the New York Stock Exchange. The independence policy is available on our website (www.manulife.com).
Each year the Board, with the assistance of the Corporate Governance and Nominating Committee, reviews the independence of each director and has determined that 14 of the 15 directors are independent and that the members of the Audit Committee and the Management Resources and Compensation Committee meet the additional independence requirements for those committees. As CEO, Donald Guloien is not independent.
Presiding Director at Meetings of Non-Management Directors.
The independent directors meet regularly with senior executives and have an opportunity to meet privately without management present during the closed session held at each Board and committee meeting. They may also use these sessions to meet privately with members of management or independent advisors.
In addition, the independent directors meet at least once each year in a closed session without the CEO present to review the performance and approve the compensation of the CEO, to review the Board’s effectiveness assessments and to approve the Board’s objectives for the following year. In 2016, one such meeting of the independent directors was held which was presided over by the Chairman of the Board.
Communication with Non-Management Directors.
Shareholders wishing to contact non-management Directors of the Company may write to the Chairman of the Board, in care of the Corporate Secretary, at the head office of the Company, 200 Bloor Street East, Toronto, Ontario, Canada, M4W 1E5.
40-F 6
Corporate Governance Guidelines.
The Company’s governance practices are consistent in all material respects with the requirements of the Insurance Companies Act (Canada), the corporate governance guidelines established by the Office of the Superintendent of Financial Institutions (Canada) and by the Canadian Securities Administrators, the New York Stock Exchange corporate governance rules for domestic issuers and the applicable U.S. Securities and Exchange Commission rules and regulations. The Company’s statement of corporate governance practices is posted on the corporate governance section of our website and is available at: http://www.manulife.com/servlet/servlet.FileDownload?file=00P5000000dfNfsEAE#Page=96
Board Committee Charters.
The Board has established four standing committees to assist it in fulfilling its mandate: Corporate Governance and Nominating Committee, Audit Committee, Risk Committee, and Management Resources and Compensation Committee.
All of the members of the standing committees are independent. Each committee reviews and, as necessary, updates its charter every year and monitors compliance with its charter on a regular basis throughout the year. Each committee chair reports to the Board on the committee’s deliberations and any recommendations that require Board approval.
The committee charters and the position description for each committee chair are posted on the corporate governance section of our website and are available at: http://www.manulife.com/Board-of-Committees
40-F 7
UNDERTAKING AND CONSENT TO SERVICE OF PROCESS
| A. | Undertaking. |
Registrant undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the securities in relation to which the obligation to file an Annual Report on Form 40-F arises; or transactions in said securities.
| B. | Consent to Service of Process. |
The Company has previously filed a Form F-X in connection with the class of securities in relation to which the obligation to file this Annual Report arises.
Any change to the name or address of the Registrant’s agent for service of process shall be communicated promptly to the Securities and Exchange Commission by an amendment to the Form F-X referencing the file number of the relevant registration statement of the Registrant.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this Annual Report to be signed on its behalf by the undersigned, thereto duly authorized, on February 9, 2017.
| Manulife Financial Corporation | ||
| By: | /s/ James D. Gallagher | |
| Name: | James D. Gallagher | |
| Title: | Executive Vice President and General Counsel | |
40-F 8
EXHIBIT INDEX
| Exhibit |
Description | |
| 99.1 | Consolidated Financial Statements for the fiscal year ended December 31, 2016 | |
| 99.2 | Management’s Discussion and Analysis for the fiscal year ended December 31, 2016 | |
| 99.3 | Annual Information Form dated February 9, 2017 for the fiscal year ended December 31, 2016 | |
| 99.4 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934 | |
| 99.5 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934 | |
| 99.6 | Section 1350 Certification of Chief Executive Officer | |
| 99.7 | Section 1350 Certification of Chief Financial Officer | |
| 99.8 | Consent of Independent Registered Public Accounting Firm | |
| 99.9 | Consent of Appointed Actuary | |